Myint Phyo Kyaw, Kwok Chun Shing, Roffe Christine, Kontopantelis Evangelos, Zaman Azfar, Berry Colin, Ludman Peter F, de Belder Mark A, Mamas Mamas A
From the Epidemiology Group, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, Scotland, UK (P.K.M.); Keele Cardiovascular Research Group, Institute of Science and Technology in Medicine, Keele University, Stoke-on-Trent, UK (C.S.K., C.R., M.A.M.); Farr Institute, University of Manchester, Manchester, UK (E.K., M.A.M.); Department of Cardiology, Freeman Hospital and Institute of Cellular Medicine, Newcastle University, Newcastle-upon-Tyne, UK (A.Z.); Department of Cardiology, Royal Jubilee Hospital, Glasgow, UK (C.B.); Department of Cardiology, Queen Elizabeth Hospital, Edgbaston, Birmingham, UK (P.F.L.); and Department of Cardiology, The James Cook University Hospital, Middlesbrough, UK (M.A.d.B.).
Stroke. 2016 Jun;47(6):1500-7. doi: 10.1161/STROKEAHA.116.012700. Epub 2016 May 10.
Stroke after percutaneous coronary intervention (PCI) is a serious complication, but its determinants and outcomes after PCI in different clinical settings are poorly documented.
The British Cardiovascular Intervention Society (BCIS) database was used to study 560 439 patients who underwent PCI in England and Wales between 2006 and 2013. We examined procedural-type specific determinants of ischemic and hemorrhagic stroke and the likelihood of subsequent 30-day mortality and in-hospital major adverse cardiovascular events (a composite of in-hospital mortality, myocardial infarction or reinfarction, and repeat revascularization).
A total of 705 stroke cases were recorded (80% ischemic). Stroke after an elective PCI or PCI for acute coronary syndrome indications was associated with a higher risk of adverse outcomes compared with those without stroke; 30-day mortality and major adverse cardiovascular events outcomes in fully adjusted model were odds ratios 37.90 (21.43-67.05) and 21.05 (13.25-33.44) for elective and 5.00 (3.96-6.31) and 6.25 (5.03-7.77) for acute coronary syndrome, respectively. Comparison of odds of these outcomes between these 2 settings showed no differences; corresponding odds ratios were 1.24 (0.64-2.43) and 0.63 (0.35-1.15), respectively.
Hemorrhagic and ischemic stroke complications are uncommon, but serious complications can occur after PCI and are independently associated with worse mortality and major adverse cardiovascular events outcomes in both the elective and acute coronary syndrome setting irrespective of stroke type. Our study provides a better understanding of the risk factors and prognosis of stroke after PCI by procedure type, allowing physicians to provide more informed advice around stroke risk after PCI and counsel patients and their families around outcomes if such neurological complications occur.
经皮冠状动脉介入治疗(PCI)后发生的卒中是一种严重并发症,但在不同临床情况下其决定因素及PCI后的结局记录较少。
利用英国心血管介入学会(BCIS)数据库研究了2006年至2013年间在英格兰和威尔士接受PCI的560439例患者。我们检查了缺血性和出血性卒中的特定手术类型决定因素以及随后30天死亡率和院内主要不良心血管事件(院内死亡率、心肌梗死或再梗死以及重复血运重建的综合指标)的可能性。
共记录了705例卒中病例(80%为缺血性)。与未发生卒中者相比,择期PCI或因急性冠状动脉综合征适应证进行PCI后发生的卒中与不良结局风险更高相关;在完全调整模型中,择期PCI的30天死亡率和主要不良心血管事件结局的比值比分别为37.90(21.43 - 67.05)和21.05(13.25 - 33.44),急性冠状动脉综合征的分别为5.00(3.96 - 6.31)和6.25(5.03 - 7.77)。这两种情况之间这些结局的比值比比较无差异;相应比值比分别为1.24(0.64 - 2.43)和0.63(0.35 - 1.15)。
出血性和缺血性卒中并发症并不常见,但PCI后可能发生严重并发症,且在择期和急性冠状动脉综合征情况下,无论卒中类型如何,均与更差的死亡率和主要不良心血管事件结局独立相关。我们的研究通过手术类型更好地了解了PCI后卒中的危险因素和预后,使医生能够围绕PCI后的卒中风险提供更明智的建议,并在发生此类神经并发症时为患者及其家属提供有关结局的咨询。